Recent research focusing on specially designed small protein chains, a innovative type of agents demonstrating considerable capability for affecting different disease mechanisms. Unlike existing small molecule methods, Nexaph peptides offer improved targeting and minimal side consequences, enabling them a truly desirable pathway for future therapeu